Replek Farm LTD is a pharmaceutical manufacturer that specializes in generic finished dosage forms. Founded in 2001 as a daughter company of REPLEK AD Shareholding Company, it has a rich history in the healthcare sector. The company is equipped with state-of-the-art technology and facilities, adhering to Good Manufacturing Practice (GMP) standards. With a focus on producing medicinal non-sterile products for human use, including solid forms, semi-solid and liquid pharmaceutical forms, as well as packaging, batch certification, food supplements, and cosmetics.
Replek Farm's business goals and objectives revolve around increasing their annual turnover by 20-30% through cost-effective production and competitive pricing. They aim to capture a significant share of the market expenditure for selected products, both domestically and internationally, over the next five years.
As a venture capital firm, investing in Replek Farm could prove to be a lucrative opportunity in the pharmaceutical industry. The company's strong foundation, adherence to quality standards, and ambitious growth targets make it an attractive prospect for investors seeking long-term potential and stability within the pharmaceutical sector.
There is no investment information
No recent news or press coverage available for Replek Farm LTD.
We care about your data, and we'd love to use cookies make your experience better.